Stakeholders have called on the Federal Government to prioritise easing local pharmaceutical manufacturers’ challenges, including a harsh trade and regulatory environment, as it seeks to attract ...

Beyond the public-facing panels and press releases of Davos, the real signal lay in who was inside and who was left outside.